In summary, the present study has identified the role of circUGP2 as a tumor suppressor in ICC through regulating ADGRB1/p53 axis, and the application of LNP provides a promising translational strategy for ICC treatment. The gene discussed is TP53; the disease is intrahepatic cholangiocarcinoma.